Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
The EMBO Journal|October 9, 2003
The roles of initiation factor 2 and guanosine triphosphate in initiation of protein synthesisAyman Antoun, Michael Y Pavlov, Kerstin Andersson, et al.
Molecular Pharmaceutics|January 20, 2023
Development of <i>In Vitro</i> and <i>Ex Vivo</i> Biofilm Models for the Assessment of Antibacterial Fibrous Electrospun Wound DressingsKairi Lorenz, Liis Preem, Kadi Sagor, et al.
Nature Reviews. Microbiology|April 9, 2015
Recent functional insights into the role of (p)ppGpp in bacterial physiologyVasili Hauryliuk, Gemma C Atkinson, Katsuhiko S Murakami, et al.
Biochimie|May 26, 2009
Cis-acting resistance peptides reveal dual ribosome inhibitory action of the macrolide josamycinMartin Lovmar, Vladimir Vimberg, Eliisa Lukk, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2008
Erythromycin- and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibitionTriinu Siibak, Lauri Peil, Liqun Xiong, et al.
The Journal of Biological Chemistry|January 18, 2006
The molecular mechanism of peptide-mediated erythromycin resistanceMartin Lovmar, Karin Nilsson, Vladimir Vimberg, et al.
Biochimie|October 14, 2018
Fragmentation of Escherichia coli mRNA by MazF and MqsRToomas Mets, Sergo Kasvandik, Merilin Saarma, et al.
Infection and Immunity|January 7, 2015
Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complementMarta Putrinš, Karin Kogermann, Eliisa Lukk, et al.
Antimicrobial Agents and Chemotherapy|September 27, 2021
Uropathogenic Escherichia coli Shows Antibiotic Tolerance and Growth Heterogeneity in an <i>In Vitro</i> Model of Intracellular InfectionIvana Kerkez, Paul M Tulkens, Tanel Tenson, et al.
The EMBO Journal|February 7, 2009
Erythromycin resistance by L4/L22 mutations and resistance masking by drug efflux pump deficiencyMartin Lovmar, Karin Nilsson, Eliisa Lukk, et al.
Pageof 16